Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17617234 | 0.91 | CYP1A2 (0.58) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL23811129 | 0.90 | ALDH1A1 (0.53) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL6050184 | 0.90 | ALDH1A1 (0.53) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL26825081 | 0.90 | CA1 (0.56) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL19002175 | 0.88 | SLC15A1 (0.57) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL28012229 | 0.88 | CA1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL3823743 | 0.87 | CA2 (0.53) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| SCHEMBL24535020 | 0.87 | ALDH1A1 (0.50) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A | |
| Phosphoric Acid SCHEMBL8654816 | 0.85 | PPARG (0.55) | ALDH1A1CYP3A4CYP1A2EPHX2PPARG | |
| SCHEMBL3247583 | 0.85 | ALDH1A1 (0.51) | ALDH1A1TDP1MAPK1L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101219963-B | Phenylcarbinol kearny ester compounds | UNIV SHANDONG | 2010-12-08 | — | — | CN | claimed |
| CN-101219963-A | Phenylcarbinol kearny ester compounds | UNIV SHANDONG (CN) | 2008-07-16 | — | — | CN | claimed |
| CN-1566078-A | Preparation method of N-(1-S-ethoxycarbonyl-3-phenyl propyl)-S-alanine | BEIJING TH UNIS INSIGHT CO LTD (CN) | 2005-01-19 | — | — | CN | claimed |
| EP-4008427-A1 | PROGRAMMABLE POLYMER DROPLETS AND ASSOCIATED USES | ETH Zurich (CH) | 2022-06-08 | — | — | EP | disclosed |
| WO-2021127328-A1 | TRPML MODULATORS | CASMA THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| WO-2019112024-A1 | PYRROLIDINE COMPOUND | キッセイ薬品工業株式会社 | 2019-06-13 | — | — | WO | disclosed |
| CN-109843283-A | Urea derivative | 第一三共株式会社 | 2019-06-04 | — | — | CN | disclosed |
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | API CORPORATION (JP) | 2016-03-24 | — | — | US | disclosed |
| US-7927581-B2 | For magnetic resonance imaging (MRI); peptide modified at its N- and its C-termini, independently, with a moiety comprising a metal chelate complex; specific binding affinity for fibrin; sufficient half-life in vivo | Factor 1A, LLC (US) | 2011-04-19 | — | — | US | disclosed |
| CN-101219963-B | Phenylcarbinol kearny ester compounds | UNIV SHANDONG | 2010-12-08 | — | — | CN | disclosed |
| US-20090291923-A1 | TRIOXANE DIMERS HAVING HIGH ANTICANCER AND LONG-LASTING ANTIMALARIAL ACTIVITIES | JOHNS HOPKINS UNIVERSOTY (US) | 2009-11-26 | — | — | US | disclosed |
| CN-101219963-A | Phenylcarbinol kearny ester compounds | UNIV SHANDONG (CN) | 2008-07-16 | — | — | CN | disclosed |
| US-7238341-B2 | Peptide-based multimeric targeted contrast agents | EPIX PHARMACEUTICALS, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-20060039861-A1 | Peptide-based multimeric targeted contrast agents | EPIX MEDICAL, INC., A DELAWARE CORPORATION | 2006-02-23 | — | — | US | disclosed |
| US-20050074411-A1 | Peptide-based multimeric targeted contrast agents | EPIX MEDICAL, INC. A DELAWARE CORPORATION | 2005-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060039861-A1 | Peptide-based multimeric targeted contrast agents | NGLY1, IAPP, NPPA | ALDH1A1 4848/4885TDP1 3429/4885MAPK1 2622/4885 |
| US-20160083341-A1 | METHOD FOR PRODUCING a-SUBSTITUTED CYSTEINE OR SALT THEREOF OR SYNTHETIC INTERMEDIATE OF a-SUBSTITUTED CYSTEINE | MGMT, GSTA1, CBS | ALDH1A1 236/4885TDP1 2534/4885MAPK1 1591/4885 |
| US-20050074411-A1 | Peptide-based multimeric targeted contrast agents | NGLY1, IAPP, NPPA | ALDH1A1 4848/4885TDP1 3429/4885MAPK1 2622/4885 |
| US-20090291923-A1 | TRIOXANE DIMERS HAVING HIGH ANTICANCER AND LONG-LASTING ANTIMALARIAL ACTIVITIES | HCCS, XPO5, DHX15 | ALDH1A1 4123/4885TDP1 3541/4885MAPK1 3511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.